Charles River Laboratories International Inc (CRL)

Industry Diagnostics & Research
This stock can be held in an Investment Account
Sell

$94.55

Buy

$151.57

arrow-up$3.38 (+2.45%)

Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
Prices updated at 20 May 2025, 09:00 BST
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. James C. Foster
CEO
Mr. James C. Foster
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
20,100
Head office
251 Ballardvale Street
Wilmington
United States
01887
mobile
+1 781 222-6000
letter
askcharlesriver@crl.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Dr. Deborah T. Kochevar, D.V.M.,PhD
Independent Director
0.09m--0.34m-
Mr. George E. Massaro
Lead Independent Director
0.12m--0.37m-
Mr. Richard F. Wallman
Independent Director
0.11m--0.36m-
Mr. Robert J. Bertolini
Independent Director
0.09m--0.35m-
Mr. Paul W. Graves
Director
-----
Mr. Mark Joseph Enyedy
Director
-----
Mr. Steven K. Barg
Director
-----
Mr. Abe Ceesay
Director
-----
Mr. James C. Foster
Chairman of the Board, President and Chief Executive Officer
1.51m--13.47m-
Dr. Martin W. Mackay, PhD
Independent Director
0.09m--0.34m-
Dr. Craig B. Thompson,M.D.
Independent Director
0.07m--0.32m-
Ms. Virginia M. Wilson
Independent Director
0.09m--0.35m-
Mr. Michael Gunnar Knell
Corporate Senior Vice President and Chief Accounting Officer
-----
Ms. Victoria L. Creamer
Corporate Executive Vice President
0.54m--2.81m-
Dr. Nancy C. Andrews, M.D.,PhD
Independent Director
0.09m--0.34m-
Ms. Birgit Girshick
Chief Operating Officer
0.74m--5.06m-
Mr. Joseph W. LaPlume
Corporate Executive Vice President, Corporate Development and Strategy
0.56m--2.98m-
Mr. George Llado, Sr
Independent Director
0.07m--0.33m-
Ms. Flavia H. Pease
Corporate Executive Vice President and Chief Financial Officer
0.65m--3.15m-
Ms. Shannon M. Parisotto
Corporate Executive Vice President
-----
Ms. Reshema Kemps-Polanco
Independent Director
0.08m--0.41m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc6,105,4780.01662-53448-0.86781430 Apr 202512.43
Wellington Management Company LLP4,285,0120.124072085865.11688430 Apr 20258.72
BlackRock Inc3,670,8250.01161-561345-13.26376330 Apr 20257.47
Wellington Management Group, LLP3,740,768-3740768-30 Apr 20257.32
Vanguard Health Care Fund1,999,1150.77253--30 Apr 20254.07

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
08 Nov 2024-Mr. James C. Foster--184,783--
07 Nov 2024-Mr. William D. Barbo--23,337--
07 Nov 2024-Mr. Richard F. Wallman216.50216,500---
07 Nov 2024-Mr. Richard F. Wallman216.50703,62512,386--
07 Nov 2024-Mr. Richard F. Wallman215.75727,29315,636--
06 Nov 2024-Mr. Richard F. Wallman--19,007--
12 Aug 2024-Mr. James C. Foster--185,751--
08 Aug 2024-Mr. Joseph W. LaPlume199.36354,86122,521--
01 Aug 2024-Mr. James C. Foster250.006,250,000188,251--
03 Jun 2024-Mr. Joseph W. LaPlume--24,301--
31 May 2024-Mr. James C. Foster208.445,181,40224,858--
31 May 2024-Mr. Michael Gunnar Knell208.44306,8241,472--
31 May 2024-Mr. Michael Gunnar Knell--8,326--
31 May 2024-Ms. Victoria L. Creamer--14,829--
31 May 2024-Ms. Victoria L. Creamer208.44931,7274,470--
31 May 2024-Ms. Birgit Girshick208.441,818,0148,722--
31 May 2024-Ms. Birgit Girshick--50,512--
31 May 2024-Mr. Joseph W. LaPlume208.44999,8874,797--
31 May 2024-Mr. Joseph W. LaPlume--24,612--
31 May 2024-Ms. Flavia H. Pease--9,760--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.